• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

‘Drug-dealing’ network shielded by blue states targeted in SCOTUS challenge

by September 30, 2026
written by September 30, 2026

Louisiana Republican Attorney General Liz Murrill is escalating her fight against abortion pills entering states that ban abortions through two lawsuits — one targeting the providers accused of distributing the drugs and another challenging the blue-state laws shielding them from prosecution.

Murrill, along with Alabama Attorney General Steve Marshall and Arkansas Attorney General Tim Griffin, sued New York, California and Massachusetts at the Supreme Court on Wednesday, alleging their shield laws block cooperation with investigations into abortion-pill providers. The attorneys general also filed a separate lawsuit in Louisiana against more than 30 people and organizations accused of advertising, prescribing, dispensing or shipping abortion pills into their states.

“This is drug dealing and it’s illegal,” Murrill told Fox News Digital. “And we’re going to continue to do everything that we can to enforce the laws in our states.”

The two lawsuits, filed Wednesday, are the latest move in a widening state-by-state fight over abortion. That conflict has grown since the Supreme Court’s 2022 ruling in Dobbs v. Jackson Women’s Health Organization, which struck down Roe v. Wade and gave elected officials the power to set abortion policy in their states.

HAWLEY SENDS CRIMINAL REFERRAL OF ‘LEFT-WING DARK-MONEY’ GROUP OVER MAILED ABORTION DRUGS

Murrill said the Supreme Court case targets the blue states’ legal protections that have thwarted Louisiana’s previous efforts to prosecute out-of-state doctors.

“These shield laws are very comprehensive,” Murrill said, arguing that California and New York prohibit officials from assisting other states seeking to enforce judgments stemming from abortion-related conduct.

Louisiana has already indicted New York physician Margaret Carpenter and California physician Remy Coeytaux over allegations that they prescribed abortion drugs that were sent into Louisiana. New York Democratic Gov. Kathy Hochul and California Democratic Gov. Gavin Newsom have refused to extradite the doctors.

The Supreme Court complaint cited Louisiana’s unsuccessful effort to extradite Carpenter, saying Hochul declared there was “no way in hell” she would comply with Louisiana’s request. The filing said New York later strengthened its shield law, including by allowing prescribers of abortion drugs to keep their names off prescription labels.

In response to the lawsuit, Hochul said she will continue fighting to ensure New York remains a “safe haven for reproductive rights.”

“No one should have to fear being punished for seeking or providing reproductive care,” Hochul said in a statement. “As anti-abortion extremists in other states try to reach across our borders and threaten patients and providers, New York will stand up for them. Our shield laws are there to protect that freedom.”

Newsom similarly rejected Louisiana’s request to extradite Coeytaux in January, saying California would not help other states punish doctors for providing abortion access that is legal in California.

CALIFORNIA ABORTION PILL SUPPLIERS PLOT WORKAROUNDS AHEAD OF SUPREME COURT MIFEPRISTONE DECISION

When Murrill vowed to sue, Newsom responded on X telling her to “Go f— yourself. California will never help you criminalize healthcare.”

“I think that if I sent guns into their states illegally, they would certainly try to come after me,” Murrill told Fox News Digital. “I said specifically at the time that we would be coming for them and we are.”

“We are going to take down those laws using every tool that we have at our disposal,” she continued.

The second lawsuit directly targets what Murrill calls the “pill pipeline.”

The 100-page complaint alleges providers used online questionnaires to obtain information from customers before abortion drugs were mailed into states where their distribution is prohibited. The states allege some organizations openly acknowledged that their conduct violated those states’ laws while relying on shield laws to protect themselves from legal consequences.

Murrill said investigators have conducted controlled purchases and received pills packaged in small bags, sometimes in quantities she said exceeded what would ordinarily be prescribed.

“We’ve seen it for ourselves,” Murrill said. “There’s no supervision, there’s no healthcare, there’s no communication whatsoever. It’s all done online.”

Murrill argued that the system can allow people other than pregnant women to obtain the drugs, pointing to cases Louisiana authorities said involved women being pressured or deceived into taking abortion medication.

PRO-LIFE LEADER SOUNDS ALARM AFTER DOCTOR GETS 6 MONTHS FOR FORCING ABORTION PILLS ON GIRLFRIEND

“We have a situation in one town in Louisiana that we’ve documented and investigated where a father did not want his teenage daughter to keep a pregnancy,” Murrill told Fox News Digital. “And so he basically put the medication in a smoothie, forced her to drink it. She did ultimately give birth to that baby at 23 weeks and is still in a NICU fighting for its life.”

The attorney general also said Louisiana wants more help from the Trump administration.

“Obviously we think the FDA could be doing more and we’ve asked them to do that,” Murrill said.

Louisiana has separately challenged federal rules that eliminated an in-person dispensing requirement for mifepristone.

Susan B. Anthony Pro-Life America President Marjorie Dannenfelser backed the litigation, accusing blue states of using their laws “to obstruct justice” and urging the Justice Department to settle Louisiana’s separate FDA litigation.

SIGN UP TO GET THE POLITICS NEWSLETTER

“Democrats’ pro-abortion extremism has brought this country to a crisis point. Abortion activists flagrantly sell dangerous drugs across state lines and women and children pay the price, with more and more survivors of ‘death in a pill’ bravely coming forward,” Dannenfelser said in a statement.

Fox News Digital reached out to New York, California and Massachusetts’ governors’ offices for comment.

This post appeared first on https://www.foxnews.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
Republican glee erupts as White House boasts sharp decline in immigration from Muslim-majority nations
next post
Micron revenue quadrupled to $54 billion but the stock fell: here’s why

related articles

State’s largest mosque leader’s deportation fight takes dramatic...

October 1, 2026

Trump handing 1 million Americans Obamacare refund checks...

October 1, 2026

Iranian negotiators kicked out of US as talks...

October 1, 2026

10 Democrat-held House seats Republicans could flip to...

October 1, 2026

Trump’s new high-tech government hub holds some bizarre...

October 1, 2026

FAA breaks controller hiring record after chief warned...

October 1, 2026

Biden-era federal prosecutor hit with criminal investigation referral...

October 1, 2026

Teen’s tragic killing by illegal immigrant becomes flashpoint...

October 1, 2026

Election crime arrests keep piling up as Dems...

October 1, 2026

States leading nation on the biggest education battles...

October 1, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • State of play: What to know about California showdown to replace Swalwell after massive scandal

    August 19, 2026
  • WATCH: Rand Paul says there’s one thing Americans have never heard from Fauci

    July 29, 2026
  • Dem mayor torches DNC in scathing letter for ‘abandoning’ Black voters after convention snub

    August 20, 2026
  • FBI warns battlefield-style drone attacks could reach US: ‘Only a matter of time’

    June 25, 2026
  • Nikkei drops as Asian markets buckle under Fed hike shock and oil rebound

    June 23, 2026

Popular Posts

  • 1

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 2

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 3

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 4

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (707)
  • Investing (1,621)
  • Stock (90)

Latest Posts

  • Evening digest: US-Iran tensions rise, SK Hynix eyes record US IPO

    July 9, 2026
  • Massive Mexico-California border busts uncover eye-popping amount of drugs: ‘Remain vigilant’

    June 5, 2026
  • Meta stock jumps 9% today: here’s why

    September 21, 2026

Recent Posts

  • Micron stock slips as Goldman warns high expectations before earnings

    June 12, 2026
  • SK Hynix’s record US listing sets stage for leveraged ETF boom: volatility ahead?

    July 10, 2026
  • Top catalysts for Japan’s Nikkei 225 and Topix indices this week

    June 29, 2026

Editor’s Pick

  • Nvidia teams up with Abridge to build AI model for healthcare: report

    June 11, 2026
  • Trump’s fiercest GOP critic became his most influential voice on war and peace

    July 14, 2026
  • Dangote Refinery IPO is here: here’s what you need to know

    September 15, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock